4
Changes in Ownership
Arcadia Biosciences, Inc. Filed Acc 0001209191-19-057375
Chief Commercial Officer bought 1,000 shares at $4.52 ($4,520)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Reiter Sarah Chief Commercial Officer | 2019-11-19 | Purchase | +1,000 | $4.52 | $4,520 | 2,200 | D |
| Open-market purchases · 1,000 sh · avg $4.52 · $4,520 | |||||||
Loading xslF345X03/doc4.xml…